Alector Inc ALEC:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 07/29/21 EDT
23.75quote price arrow down-0.32 (-1.33%)
Volume
24,609
Close
24.07quote price arrow down-6.43 (-21.08%)
Volume
2,753,347
52 week range
9.12 - 43.32

...

Loading . . .
  • Open30.52
  • Day High31.24
  • Day Low23.77
  • Prev Close24.07
  • 52 Week High43.32
  • 52 Week High Date07/02/21
  • 52 Week Low9.12
  • 52 Week Low Date10/30/20

Key Stats

  • Market Cap1.92B
  • Shares Out79.77M
  • 10 Day Average Volume1.10M
  • Dividend-
  • Dividend Yield-
  • Beta1.04
  • YTD % Change59.09

KEY STATS

  • Open30.52
  • Day High31.24
  • Day Low23.77
  • Prev Close24.07
  • 52 Week High43.32
  • 52 Week High Date07/02/21
  • 52 Week Low9.12
  • 52 Week Low Date10/30/20
  • Market Cap1.92B
  • Shares Out79.77M
  • 10 Day Average Volume1.10M
  • Dividend-
  • Dividend Yield-
  • Beta1.04
  • YTD % Change59.09

RATIOS/PROFITABILITY

  • EPS (TTM)-2.56
  • P/E (TTM)-9.39
  • Fwd P/E (NTM)-14.45
  • EBITDA (MRQ)-199.766M
  • ROE (MRQ)-65.33%
  • Revenue (MRQ)18.04M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-1,122.03%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Alector Inc

There is no recent news for this security.

Profile

MORE
Alector, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration. Immuno-neurology targets immune dysfunction as a cause of multiple pathologies that are drivers of degenerative brain disorders. The Company is developing therapies designed to simultaneously counteract these pathologies by restoring healthy immune function to the brain. The Company's platform leverages...
Tillman Gerngross Ph.D.
Chairman
Arnon Rosenthal Ph.D.
Chief Executive Officer
Shehnaaz Suliman M.D.
President
Calvin Yu
Vice President - Finance
Address
151 Oyster Point Blvd Ste 300
South San Francisco, CA
94080-1841
United States

Top Peers

SYMBOLLASTCHG%CHG
IGMS
IGM Biosciences Inc
78.76-0.76-0.96%
ALXO
ALX Oncology Holdings Inc
59.45+1.23+2.11%
RCKT
Rocket Pharmaceuticals Inc
38.04-0.86-2.21%
PRTA
Prothena Corporation PLC
49.72-3.02-5.73%
ITCI
Intra-Cellular Therapies Inc
35.19+0.36+1.03%